8-K: Amprius Completes $97.5M ATM Equity Offering
Equity Offering Completion
Amprius Technologies, Inc. announced the successful completion of its at-the-market equity offering program, raising approximately $97.5 million in net proceeds.
Summary
- Amprius Technologies, Inc. successfully completed its At-The-Market (ATM) equity offering program.
- The program, established on October 2, 2023, authorized the sale of common stock up to an aggregate offering price of $100.0 million.
- The company issued a total of 25.5 million shares of common stock under the program.
- This resulted in aggregate net proceeds of approximately $97.5 million to the company.
- During the three months ended December 31, 2025, the company sold shares yielding approximately $19.6 million in net proceeds at an average price of $11.17 per share.
- The Sales Agreement has been terminated following the sale of all available shares, and no further sales under the ATM Program are intended.
Sentiment
Score: 7
Explanation: The successful completion of a significant capital raise is a positive for the company's financial health and ability to fund operations. However, the substantial dilution from issuing 25.5 million shares and the continuous selling pressure from an ATM program can be a negative for existing shareholders, balancing the overall sentiment.
Positives
- Successfully completed the ATM program, securing significant capital for operations and growth.
- Raised approximately $97.5 million in net proceeds, substantially strengthening the company's financial position.
- Demonstrates the company's ability to effectively access capital markets to fund its strategic initiatives.
Negatives
- The issuance of 25.5 million new shares of common stock likely resulted in significant dilution for existing shareholders.
- The continuous selling of shares through an ATM program can exert downward pressure on the stock price over the offering period.
Risks
- Dilution of existing shareholders due to the issuance of 25.5 million new shares of common stock.
- Potential for continued downward pressure on the share price if the market perceives the capital raise as a sign of financial strain or if future capital needs arise.
Future Outlook
The company has concluded its At-The-Market equity offering program and does not intend to make any further sales under the terminated Sales Agreement. No other forward-looking statements or guidance regarding future operational or financial performance were provided in this filing.
Management Comments
- The company does not intend to make any further sales under the Sales Agreement, and the ATM Program is concluded.
Industry Context
This capital raise provides Amprius, a company in the advanced battery technology sector, with significant funds crucial for operations, research and development, or scaling production. In a capital-intensive industry like advanced materials or energy storage, securing nearly $100 million is vital for maintaining competitiveness and funding growth initiatives against larger, more established players or other innovative startups.
Comparison to Industry Standards
- Many growth-stage technology companies, particularly in capital-intensive sectors like advanced battery manufacturing, frequently utilize ATM programs to raise capital incrementally without the significant upfront costs and market disruption of a traditional follow-on offering.
- The $97.5 million raised is a substantial amount for a company of this likely size, comparable to capital raises seen in other emerging battery technology firms like Solid Power or QuantumScape during their development phases, which also rely on equity financing to fund R&D and scale-up.
- The average price of $11.17 per share during Q4 2025 for the ATM sales suggests market demand for the stock, though the overall impact on the stock price during the entire program would need a broader market analysis.
Stakeholder Impact
- Shareholders: Existing shareholders experienced dilution due to the issuance of 25.5 million new shares. However, the capital raise strengthens the company's financial position, potentially supporting future growth and value creation.
- Company Operations: The company now has approximately $97.5 million in net proceeds to fund its strategic initiatives, research and development, and operational needs, which could accelerate product development and market expansion.
Next Steps
- The company will continue its operations, utilizing the newly raised capital to fund strategic initiatives.
- No further sales under the terminated Sales Agreement are intended.
Key Dates
| Date | Description |
|---|---|
| 2023-10-02 | Date of the At Market Issuance Sales Agreement establishment with Sales Agents. |
| 2025-12-31 | End of the three-month period during which approximately $19.6 million in net proceeds were raised at an average price of $11.17 per share. |
| 2026-01-12 | Date of the announcement of the successful completion of the ATM Program and termination of the Sales Agreement. |
Recommendation
holdThe successful completion of the ATM program provides Amprius with substantial capital, which is crucial for a growth-stage technology company. This funding reduces immediate liquidity concerns and supports ongoing development and scaling efforts. However, the significant dilution from issuing 25.5 million shares and the potential for past selling pressure from the ATM program could weigh on the stock's performance. Investors should hold to observe how the company deploys this capital and if it translates into tangible operational improvements and revenue growth, offsetting the dilution.
Keywords
Amprius Technologies, AMPX, ATM Program, Equity Offering, Capital Raise, Common Stock, SEC Filing, 8-K, Dilution, Financial Markets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.